Bank of New York Mellon Corp - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 133 filers reported holding DIPLOMAT PHARMACY INC in Q2 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q4 2019$2,622,000
-17.7%
655,472
+0.8%
0.00%0.0%
Q3 2019$3,187,000
-22.7%
650,314
-4.0%
0.00%0.0%
Q2 2019$4,125,000
+9.6%
677,345
+4.5%
0.00%0.0%
Q1 2019$3,765,000
-83.4%
648,018
-61.5%
0.00%
-85.7%
Q4 2018$22,648,000
+36.9%
1,682,590
+97.5%
0.01%
+75.0%
Q3 2018$16,540,000
-26.0%
852,154
-2.6%
0.00%
-33.3%
Q2 2018$22,364,000
+21.4%
874,946
-4.3%
0.01%
+20.0%
Q1 2018$18,421,000
+45.4%
914,181
+44.8%
0.01%
+66.7%
Q4 2017$12,673,000
+1.4%
631,364
+4.6%
0.00%0.0%
Q3 2017$12,499,000
+44.7%
603,527
+3.4%
0.00%
+50.0%
Q2 2017$8,636,000
-5.5%
583,597
+1.9%
0.00%
-33.3%
Q1 2017$9,137,000
+31.9%
572,791
+4.2%
0.00%
+50.0%
Q4 2016$6,927,000
-55.2%
549,717
-0.5%
0.00%
-60.0%
Q3 2016$15,470,000
-9.6%
552,286
+12.9%
0.01%0.0%
Q2 2016$17,122,000
+26.6%
489,176
-0.9%
0.01%
+25.0%
Q1 2016$13,520,000
+61.6%
493,467
+101.8%
0.00%
+33.3%
Q4 2015$8,367,000
+1.1%
244,542
-15.1%
0.00%0.0%
Q3 2015$8,277,000
-38.6%
288,099
-4.4%
0.00%
-25.0%
Q2 2015$13,483,000
+326.7%
301,302
+229.7%
0.00%
+300.0%
Q1 2015$3,160,000
+110.9%
91,389
+67.0%
0.00%
Q4 2014$1,498,00054,7110.00%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q2 2019
NameSharesValueWeighting ↓
Empirical Capital Management, LLC 479,018$9,298,0008.38%
Rhenman & Partners Asset Management AB 1,174,411$22,795,0002.28%
Capital Investment Advisory Services, LLC 153,842$2,986,0001.40%
Cortina Asset Management, LLC 1,238,420$24,038,0001.12%
Investors Research Corp 92,027$1,786,0001.02%
Matarin Capital Management, LLC 697,387$13,536,282,0000.87%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 853,687$16,570,0000.59%
RICE HALL JAMES & ASSOCIATES, LLC 809,257$15,708,0000.56%
BROADVIEW ADVISORS LLC 156,700$3,042,0000.52%
FRONTIER CAPITAL MANAGEMENT CO LLC 3,535,217$68,619,0000.44%
View complete list of DIPLOMAT PHARMACY INC shareholders